Clozapine Alone versus Clozapine and Risperidone with Refractory Schizophrenia | Zendy

William G. Honer | Zendy; Allen E. Thornton | Zendy; Eric Chen | Zendy; Raymond C. K. Chan | Zendy; Jessica Wong | Zendy; A Bergmann | Zendy; Peter Falkai | Zendy; Edith PomarolClotet | Zendy; Peter J. McKenna | Zendy; Émmanuel Stip | Zendy; Richard L. Williams | Zendy; G. William MacEwan | Zendy; Kishor M. Wasan | Zendy; Ric M. Procyshyn | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clozapine Alone versus Clozapine and Risperidone with Refractory Schizophrenia

Author(s) -

William G. Honer,

Allen E. Thornton,

Eric Chen,

Raymond C. K. Chan,

Jessica Wong,

A Bergmann,

Peter Falkai,

Edith PomarolClotet,

Peter J. McKenna,

Émmanuel Stip,

Richard L. Williams,

G. William MacEwan,

Kishor M. Wasan,

Ric M. Procyshyn

Publication year - 2006

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa053222

Subject(s) - risperidone , placebo , medicine , clozapine , positive and negative syndrome scale , schizophrenia (object oriented programming) , antipsychotic , atypical antipsychotic , refractory (planetary science) , randomized controlled trial , psychiatry , psychosis , alternative medicine , physics , pathology , astrobiology

The treatment of schizophrenia with multiple antipsychotic drugs is common, but the benefits and risks are not known.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research